# Laura A. Vallow

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/laura-a-vallow/

## Facts

| Field | Value |
| --- | --- |
| Citations | 2,540 |
| Field | Breast Cancer Treatment Studies |
| h-index | 23 |
| i10-index | 42 |
| Last Known Institution | Jacksonville College |
| OpenAlex ID | https://openalex.org/A5042478985 |
| Works | 161 |

## Researcher papers

- [Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial](https://scholariq.org/papers/long-term-primary-results-of-accelerated-partial-breast-irradiation-after-breast/)
- [RTOG 9804: A Prospective Randomized Trial for Good-Risk Ductal Carcinoma In Situ Comparing Radiotherapy With Observation](https://scholariq.org/papers/rtog-9804-a-prospective-randomized-trial-for-good-risk-ductal-carcinoma-in-situ/)
- [Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial](https://scholariq.org/papers/anastrozole-versus-tamoxifen-in-postmenopausal-women-with-ductal-carcinoma-in/)
- [Prognostic factors in Merkel cell carcinoma: Analysis of 240 cases](https://scholariq.org/papers/prognostic-factors-in-merkel-cell-carcinoma-analysis-of-240-cases/)
- [Patient-reported outcomes with anastrozole versus tamoxifen for postmenopausal patients with ductal carcinoma in situ treated with lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial](https://scholariq.org/papers/patient-reported-outcomes-with-anastrozole-versus-tamoxifen-for-postmenopausal/)
- [Unknown primary Merkel cell carcinoma: 23 new cases and a review](https://scholariq.org/papers/unknown-primary-merkel-cell-carcinoma-23-new-cases-and-a-review/)
- [Clinical outcomes after a diagnosis of brain metastases in patients with estrogen- and/or human epidermal growth factor receptor 2-positive versus triple-negative breast cancer](https://scholariq.org/papers/clinical-outcomes-after-a-diagnosis-of-brain-metastases-in-patients-with/)
- [Stereotactic Radiosurgery and Immune Checkpoint Inhibitors in the Management of Brain Metastases](https://scholariq.org/papers/stereotactic-radiosurgery-and-immune-checkpoint-inhibitors-in-the-management-of/)
- [A Clinical Trial of Breast Radiation Therapy Versus Breast and Regional Radiation Therapy in Early-Stage Breast Cancer: The MA20 Trial](https://scholariq.org/papers/a-clinical-trial-of-breast-radiation-therapy-versus-breast-and-regional/)
- [Google Search Trends in Oncology and the Impact of Celebrity Cancer Awareness](https://scholariq.org/papers/google-search-trends-in-oncology-and-the-impact-of-celebrity-cancer-awareness/)
- [Is breast conservation superior to mastectomy in early stage triple negative breast cancer?](https://scholariq.org/papers/is-breast-conservation-superior-to-mastectomy-in-early-stage-triple-negative/)

## Researcher topics

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Advanced Radiotherapy Techniques](https://scholariq.org/topics/advanced-radiotherapy-techniques/)
- [Breast Lesions and Carcinomas](https://scholariq.org/topics/breast-lesions-and-carcinomas/)
- [Management of metastatic bone disease](https://scholariq.org/topics/management-of-metastatic-bone-disease/)
- [Medical Imaging Techniques and Applications](https://scholariq.org/topics/medical-imaging-techniques-and-applications/)

## Researcher university

- [Jacksonville College](https://scholariq.org/institutions/jacksonville-college/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.